| (210) | Number of the EPO application | 16845181 |
| (220) | Filing date of the EPO application | 2016.09.09 |
| (80) | EPO patent specification publication (B) | EPB nr. 23/2023, 2023.06.07 |
| (110) | EPO patent number | 3347002 |
| (11) | Number of the document | MD 3347002 T2 |
| (21) | Number of the application | e 2018 0700 |
| (71) | Name(s) of applicant(s), code of the country | Alzheon, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | ABUSHAKRA Susan, US;
POWER Aidan, US;
TOLAR Martin, US;
HEY John, US;
YU Jeremy, US;
KOCIS Petr, US; |
| (73) | Name(s) of owner(s), code of the country | Alzheon, Inc., US; |
| (54) | Title of the invention | Treatment of Alzheimer's disease in a particular patient population |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/185 (2006.01.01); A61K 31/205 (2006.01.01); C07C 309/02 (2006.01.01); A61P 25/28 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.08.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.10.31 |
| (30) | Priority | 201562216404 P, 2015.09.10, US; 201662290287 P, 2016.02.02, US; 201662302027 P, 2016.03.01, US; 201662365809 P, 2016.07.22, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2016/051091, 2016.09.09 |
| (87) | International publication | WO 2017/044840, 2017.03.16 |